Article: Oxycyte on track as oxygen carrier, not blood substitute.

Oxycyte on track as oxygen carrier, not blood substitute

By LYNN YOFFEE

Medical Device Daily Staff Writer

In light of last week's news that blood substitutes have led to a 30% increase in the risk of death and a nearly threefold chance of having a heart attack, Synthetic Blood International (SBI; Costa Mesa, California) has reiterated that its Oxycyte is not a synthetic blood and is not hemoglobin-based.

Despite the company's name, its flagship product Oxycyte is being developed as a therapeutic oxygen carrier, with application first as a treatment for traumatic brain injury and, if found to be successful, a slew of other potential ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!